Type IA variation for application Roszdravnadzor-2021-0019. Type IA variation: Specification Change for Atezolimumab-R — minor update

Variation Number
Roszdravnadzor-2021-0019-V419
Type
Type IA
Status
Completed
Fee
€2,435
Submitted
2024-02-04
Approved
—
Description

Type IA variation: Specification Change for Atezolimumab-R — minor update